2013

Dalibor Blazek, PhD

August 17, 2019

Dalibor Blazek, PhDMasaryk University (Czech Republic) The Roles of Cdk12 in Ovarian Tumorigenesis Recent comprehensive genomic analyses of patient samples have revealed the virtually unstudied cyclin-dependent kinase 12 (Cdk12) as a novel player in ovarian tumorigenesis. Dr. Blazek has already determined that Cdk12 maintains genome stability via the transcriptional regulation of key DNA-damage response genes, […]

Read More

Matjaz Barboric, PhD

August 17, 2019

Matjaz Barboric, PhDUniversity of Helsinki Examining the Tumor Suppressor Function of Cdk12/CycK Kinase in Ovarian Cancer Failure to understand key mechanisms contributing to the onset of high-grade serous ovarian cancer represents a barrier to diagnosis and treatment of this fifth-leading cause of death among American women. One of the likely factors promoting the disease is […]

Read More

Nuzhat Ahmed, PhD

August 17, 2019

Nuzhat Ahmed, PhDWomen’s Cancer Research Center (Australia) Determining the MicroRNA Signature of Isolated Chemoresistant Ascites Tumor Cells Despite advances in treatment, almost 80% of ovarian cancer patients suffer disease recurrence and succumb to the disease within 5 years of diagnosis. Cancer stem cells are a small population of drug resistant tumor cells that survive chemotherapy […]

Read More

Martin Matzuk, MD, PhD

August 16, 2019

Martin Matzuk, MD, PhDBaylor College of Medicine 2013 Challenge Grant Award Recipient  Molecular Imaging of the Dicer/Pten Mouse Model Tumor Microenvironment Dr. Matzuk’s project will use Dicer-Pten mutant mice, which closely model human high-grade serous carcinoma with tumors arising in the fallopian tubes. A state-of-the-art tissue-based mass spectrometry imaging platform will provide the approach for […]

Read More